Detalhe da pesquisa
1.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(18): 1672-1684, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870974
2.
Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumabâ¯+â¯Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial.
Clin Lung Cancer
; 23(3): e247-e251, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34819266